Advances of BCL ⁃ 2 inhibitor Venetoclaxfor higher ⁃ risk groups of myelodysplastic syndromes

LIU Yi, PEI Renzhi.
The Journal of Practical Medicine . 2022, (16): 2106 -2109 .  DOI: 10.3969/j.issn.1006⁃5725.2022.16.023